4SC AG INH. O.N./ DE000A3E5C40 /
| 2024-06-05 7:31:08 PM | Chg. -0.180 | Volume | Bid7:31:12 PM | Ask7:31:12 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 7.820EUR | -2.25% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 81.92 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018
